Checkpoint Therapeutics, Inc. (CKPT)

Checkpoint Therapeutics Revenue

Checkpoint Therapeutics had revenue of $41.00K in the twelve months ending March 31, 2025, down -39.71% year-over-year. In the year 2024, Checkpoint Therapeutics had annual revenue of $41.00K, down -60.19%.

• Revenue (ttm): $41.00K
• Revenue Growth: -39.71%
• P/S Ratio: 8,703.26
• Revenue / Employee: $1,708
• Employees: 24
• Market Cap: 356.83M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	41.00K	-62.00K	-60.19%
Dec 31, 2023	103.00K	-89.00K	-46.35%
Dec 31, 2022	192.00K	-76.00K	-28.36%
Dec 31, 2021	268.00K	-801.00K	-74.93%
Dec 31, 2020	1.07M	-639.00K	-37.41%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.